The Fatty Liver Alliance Key Areas of Focus

---

Our Mission:

We raise awareness about the risks, causes and complications of fatty liver disease and help those already diagnosed with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) by advocating for access to approved treatments and care.

Our Vision:

To live in a country where fatty liver disease is prevented and all patients who need treatment are able to receive the best available tailored care.

Our Purpose:

To educate the public about the risks, causes, effects and complications of, and treatments for, non-alcoholic fatty liver disease through virtual and in-person presentations, conferences, meetings, and webinars, and by collecting and disseminating information on that topic. 

To promote health by conducting or funding research into the causes, controls and cure of non-alcoholic fatty liver disease and by making the results available to the public.

Aiming to establish Fatty Liver Alliance as the trusted voice in Fatty Liver Disease, we are intensifying our educational efforts, targeting medical professionals, patients, and the broader community. Initiatives such as community events, social media posts, fireside chats with liver experts and the annual Primary Care Summit play pivotal roles in this endeavor. This pillar is essential for driving changes at the grassroots level and establishing FLA as a thought leader. 

FLA is reinforcing its global presence and domestic influence. By actively participating in global liver and metabolic disease conferences and representing Canada in international liver health discussions, we're striving to be Canada's go-to authority for MASLD/MASH. This pillar is also key to becoming a trusted partner in Canada for all MASLD/MASH activities, solidifying FLA's role as "the voice" of these conditions nationally. 

Acknowledging the significance of shaping public policy, we consistently engage with governmental bodies to advocate for legislative modifications, ensuring better care and services for MASLD/MASH patients. This facet underscores FLA's role in guiding public policy and healthcare benchmarks. Through ongoing dialogues with government agencies, involvement in advisory panels, and public statements, FLA seeks to influence legislative shifts. This contributes to the long-term enhancement of treatment access and services for MASLD/MASH patients. This pillar ensures that all other pillars can be effectively executed and that the organization remains financially healthy and impactful.